OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Renal Cell Carcinoma|Ovarian Carcinoma|Thyroid Carcinoma|Breast Carcinoma|Endometrium Carcinoma
Interventions: DRUG: Olaparib|DRUG: Lenvatinib|DRUG: Sunitinib|DRUG: Palbociclib|DRUG: Pazopanib|DRUG: Olaparib|DRUG: Lenvatinib|DRUG: Sunitinib|DRUG: Palbociclib|DRUG: Pazopanib
Sponsor: University Medical Center Groningen